Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
Rates of Human papilloma virus (HPV) vaccination among pediatric survivors of cancer and patients with sickle cell disease are lower than the national average. While recent attention has focused on patient HPV vaccine hesitancy and refusal, less is known about provider-level and system-level barrier...
Main Authors: | Meagan E. Miller, Mahvish Q. Rahim, Scott L. Coven, Seethal A. Jacob, Gregory D. Zimet, Carolyn G. Meagher, Mary A. Ott |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-08-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2023.2224089 |
Similar Items
-
Pediatric hematology/oncology physician and nurse practitioner attitudes towards the COVID-19 vaccines: A qualitative study
by: Meagan E. Miller, et al.
Published: (2022-11-01) -
Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective
by: Mansoor A. Khan, et al.
Published: (2020-02-01) -
Intestinal barrier functions in hematologic and oncologic diseases
by: Elio Haroun, et al.
Published: (2023-03-01) -
A cancer disparities curriculum in a hematology/oncology fellowship program
by: Marium Husain, et al.
Published: (2023-10-01) -
Ethical competence in DNR decisions –a qualitative study of Swedish physicians and nurses working in hematology and oncology care
by: Mona Pettersson, et al.
Published: (2018-06-01)